Background
Methods
Intervention
Outcome
Sample size and statistical analyses
Results
Characteristics | SINAagroup | GINAb group |
pvalue |
---|---|---|---|
Number of patients | 45 | 45 | |
Age, years (± SD) | 42.9 (± 13.4) | 42.3 (± 12.6) | 0.840 |
Gender | |||
- Male, No. (%) | 14 (31.1%) | 19 (42.2%) | 0.274 |
- Female, No. (%) | 31 (68.9%) | 26 (57.8%) | |
Body mass index, No. (± SD) | 32.6 (± 7.4) | 34.0 (± 7.3) | 0.370 |
Disease duration, years (± SD) | 10.9 (± 9.3) | 10.1 (± 8.6) | 0.630 |
Respiratory Symptoms | |||
- Cough, No. (%) | 27 (60.0%) | 22 (48.9%) | 0.290 |
- Shortness of breath, No. (%) | 10 (22.2%) | 15 (33.3%) | 0.239 |
- Wheezing, No. (%) | 7 (15.6%) | 9 (20.0%) | 0.581 |
Asthma attacks in the past 4 weeks, No. (%) | 1.5 (± 1.1) | 1.8 (± 1.5) | 0.378 |
Initial visit Peak Flow meter, value (± SD) (L/min) | 343.1 (± 129.5) | 362.9 (± 148.8) | 0.143 |
Initial visit Forced Expiratory volume in 1 second, Percentage of normal (± SD) | 81.4% (± 17.1) | 84.3% (± 16.2) | 0.269 |
Initial visit asthma control test score, score (± SD) | 17.6 (± 4.5) | 17.8 (± 3.6) | 0.776 |
Characteristics | SINAagroup | GINAb group |
p-value |
---|---|---|---|
Forced expiratory volume in 1 second | |||
- First visit--No. (± SD) | 81.4% (± 17.1%) | 84.3% (± 16.2%) | 0.269 |
- Follow-up visit--No. (± SD) | 87.2 (± 14.7%) | 87.7 (± 17.6) | 0.697 |
- Difference between two visits--No. (± SD) | 5.8% (± 12.8) | 3.4% (± 13.9) | 0.46 |
Peak flow meter
| |||
- First visit--No. (± SD) | 343.1 (± 129.3) | 362.9 (± 148.8) | 0.503 |
- Follow-up visit--No. (± SD) | 389 (± 120.5) | 423.1 (± 116.6) | 0.182 |
- Difference between two visits--No. (± SD) | 46.84 (63.3%) | 60.7 (± 77.8) | 0.803 |
Asthma control test score
| |||
- First visit--No. (± SD) | 17.6 (± 4.5) | 17.8 (± 3.6) | 0.776 |
- Follow-up visit--No. (± SD) | 20.5 (± 3.5) | 19.5 (± 3.3) | 0.43 |
- Difference between two visits--No. (± SD) | 2.9 (± 3.1) | 1.7 (± 2.9) | 0.04 |